Steven Joseph Romano's most recent trade in Dianthus Therapeutics Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics Inc | Steven Joseph Romano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Silence Therapeutics Plc -... | Steven Joseph Romano | EVP and Chief R&D Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 285,000 | 285,000 | - | - | Employee Share Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Steven Joseph Romano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |